Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers

Objective: The active transport of iodide into thyroid cells is mediated by the NaC/IK symporter (NIS) located in the basolateral membrane. Strong intracellular staining with anti-NIS antibodies has been reported in thyroid and breast cancers. Our initial objective was to screen tumour samples for i...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/27845
Acceso en línea:
https://doi.org/10.1530/EJE-08-0505
https://repository.urosario.edu.co/handle/10336/27845
Palabra clave:
Sodium iodide
Cancers
Tumours
Rights
License
Abierto (Texto Completo)
id EDOCUR2_b9e6f58a930393629b985d3ebac73f9e
oai_identifier_str oai:repository.urosario.edu.co:10336/27845
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 3bb0b075-4725-4f39-837b-af3b0462677c-134fb57a5-f7d8-4944-8cc1-4652235ae176-15dc14801-557b-49da-b3ee-c4966e4bb9cb-1cd1d2ae2-e527-437d-9aaf-bb76aef155f5-10214755d-bf17-4806-807b-ced402031b86-1a002a90c-f6f0-4516-90ac-46d4e89575df-1b60fb0ae-95cb-4194-aede-711b44b93881-146b7ca9f-ed83-4484-8c06-b33355f85170-1e6f92ec2-5c07-4d1e-8844-ff9762ecd9f5-1798319816002020-08-19T14:44:12Z2020-08-19T14:44:12Z2009-02Objective: The active transport of iodide into thyroid cells is mediated by the NaC/IK symporter (NIS) located in the basolateral membrane. Strong intracellular staining with anti-NIS antibodies has been reported in thyroid and breast cancers. Our initial objective was to screen tumour samples for intracellular NIS staining and then to study the mechanisms underlying the altered subcellular localization of the transporters. Methods: Immunostaining using three different anti-NIS antibodies was performed on paraffinembedded tissue sections from 93 thyroid or breast cancers. Western blot experiments were carried out to determine the amount of NIS protein in 20 samples. Results: Using three different anti-NIS antibodies, we observed intracellular staining in a majority of thyroid tumour samples. Control immunohistochemistry and western blot experiments indicated that this intracellular staining was due to non-specific binding of the antibodies. In breast tumours, very weak intracellular staining was observed in some samples. Western blot experiments suggest that this labelling is also non-specific. Conclusions: Our results strongly indicate that the NIS protein level is low in thyroid and breast cancers and that the intracellular staining obtained with anti-NIS antibodies corresponds to a non-specific signal. Accordingly, to increase the efficiency of radiotherapy for thyroid cancers and to enable the use of radioiodine in the diagnosis and therapy of breast tumours, improving NIS targeting to the plasma membrane will not be sufficient. Instead, increasing the expression level of NIS should remain the major goal of this field.application/pdfhttps://doi.org/10.1530/EJE-08-0505ISSN: 0804-4643EISSN: 1479-683Xhttps://repository.urosario.edu.co/handle/10336/27845engEuropean Society of EndocrinologyBioscientifica225No. 2215European Journal of EndocrinologyVol. 160European Journal of Endocrinology, ISSN: 0804-4643;EISSN: 1479-683X, Vol.160, No.2 (2009); pp. 215-225https://eje.bioscientifica.com/view/journals/eje/160/2/215.xmlAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2European Journal of Endocrinologyinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURSodium iodideCancersTumoursImmunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancersEl inmunoanálisis indica que el simportador de yoduro de sodio no se sobreexpresa en los compartimentos intracelulares en los cánceres de tiroides y mamaarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Peyrottes, IsabelleNavarro, ValerieMarcellin, DidierBellanger, LaurentMarsault, RobertLindenthal, SabineEttore, FrancetteDarcourt, JacquesPourcher, ThierryOndo Méndez, Alejandro Oyono10336/27845oai:repository.urosario.edu.co:10336/278452021-06-03 00:51:04.623https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
dc.title.TranslatedTitle.spa.fl_str_mv El inmunoanálisis indica que el simportador de yoduro de sodio no se sobreexpresa en los compartimentos intracelulares en los cánceres de tiroides y mama
title Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
spellingShingle Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
Sodium iodide
Cancers
Tumours
title_short Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
title_full Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
title_fullStr Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
title_full_unstemmed Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
title_sort Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers
dc.subject.keyword.spa.fl_str_mv Sodium iodide
Cancers
Tumours
topic Sodium iodide
Cancers
Tumours
description Objective: The active transport of iodide into thyroid cells is mediated by the NaC/IK symporter (NIS) located in the basolateral membrane. Strong intracellular staining with anti-NIS antibodies has been reported in thyroid and breast cancers. Our initial objective was to screen tumour samples for intracellular NIS staining and then to study the mechanisms underlying the altered subcellular localization of the transporters. Methods: Immunostaining using three different anti-NIS antibodies was performed on paraffinembedded tissue sections from 93 thyroid or breast cancers. Western blot experiments were carried out to determine the amount of NIS protein in 20 samples. Results: Using three different anti-NIS antibodies, we observed intracellular staining in a majority of thyroid tumour samples. Control immunohistochemistry and western blot experiments indicated that this intracellular staining was due to non-specific binding of the antibodies. In breast tumours, very weak intracellular staining was observed in some samples. Western blot experiments suggest that this labelling is also non-specific. Conclusions: Our results strongly indicate that the NIS protein level is low in thyroid and breast cancers and that the intracellular staining obtained with anti-NIS antibodies corresponds to a non-specific signal. Accordingly, to increase the efficiency of radiotherapy for thyroid cancers and to enable the use of radioiodine in the diagnosis and therapy of breast tumours, improving NIS targeting to the plasma membrane will not be sufficient. Instead, increasing the expression level of NIS should remain the major goal of this field.
publishDate 2009
dc.date.created.spa.fl_str_mv 2009-02
dc.date.accessioned.none.fl_str_mv 2020-08-19T14:44:12Z
dc.date.available.none.fl_str_mv 2020-08-19T14:44:12Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1530/EJE-08-0505
dc.identifier.issn.none.fl_str_mv ISSN: 0804-4643
EISSN: 1479-683X
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/27845
url https://doi.org/10.1530/EJE-08-0505
https://repository.urosario.edu.co/handle/10336/27845
identifier_str_mv ISSN: 0804-4643
EISSN: 1479-683X
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 225
dc.relation.citationIssue.none.fl_str_mv No. 2
dc.relation.citationStartPage.none.fl_str_mv 215
dc.relation.citationTitle.none.fl_str_mv European Journal of Endocrinology
dc.relation.citationVolume.none.fl_str_mv Vol. 160
dc.relation.ispartof.spa.fl_str_mv European Journal of Endocrinology, ISSN: 0804-4643;EISSN: 1479-683X, Vol.160, No.2 (2009); pp. 215-225
dc.relation.uri.spa.fl_str_mv https://eje.bioscientifica.com/view/journals/eje/160/2/215.xml
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv European Society of Endocrinology
Bioscientifica
dc.source.spa.fl_str_mv European Journal of Endocrinology
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1818106881230503936